These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16952205)

  • 1. Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study.
    Collie A; Maruff P; Snyder PJ; Darekar MA; Huggins JP
    Hum Psychopharmacol; 2006 Oct; 21(7):481-8. PubMed ID: 16952205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study.
    Collie A; Darekar A; Weissgerber G; Toh MK; Snyder PJ; Maruff P; Huggins JP
    Contemp Clin Trials; 2007 Jul; 28(4):391-400. PubMed ID: 17267292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol.
    Padmanabhan U; Leslie K; Eer AS; Maruff P; Silbert BS
    Anesth Analg; 2009 Nov; 109(5):1448-55. PubMed ID: 19617584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam causes less sedation in volunteers with red hair.
    Chua MV; Tsueda K; Doufas AG
    Can J Anaesth; 2004 Jan; 51(1):25-30. PubMed ID: 14709456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated Endoscopic Pancreatic Function Test (ePFT).
    Conwell DL; Zuccaro G; Purich E; Fein S; Vanlente F; Vargo J; Dumot J; O'laughlin C; Trolli P
    Am J Gastroenterol; 2005 May; 100(5):1161-6. PubMed ID: 15842594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paradoxical dissociation in the effects of midazolam on recollection and automatic processes in the process dissociation procedure.
    Mintzer MZ; Griffiths RR; Hirshman E
    Am J Psychol; 2003; 116(2):213-37. PubMed ID: 12762176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premedication with orally administered lorazepam in adults undergoing ERCP: a randomized double-blind study.
    Weitz G; Homann N; von Jagow DC; Wellhöner P; Sauer A; Ludwig D
    Gastrointest Endosc; 2007 Sep; 66(3):450-6. PubMed ID: 17725934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam--a pilot study.
    Sackey PV; Martling CR; Carlswärd C; Sundin O; Radell PJ
    Crit Care Med; 2008 Mar; 36(3):801-6. PubMed ID: 18431266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.